Literature DB >> 31479396

Tension-Free Vaginal Tape Surgery versus Polyacrylamide Hydrogel Injection for Primary Stress Urinary Incontinence: A Randomized Clinical Trial.

Anna-Maija Itkonen Freitas1, Maarit Mentula1, Päivi Rahkola-Soisalo1, Sari Tulokas2, Tomi S Mikkola1,3.   

Abstract

PURPOSE: We evaluated whether polyacrylamide hydrogel is noninferior to tension-free vaginal tape to treat women with primary stress urinary incontinence.
MATERIALS AND METHODS: In this controlled noninferiority clinical trial patients with primary stress urinary incontinence were randomized to tension-free vaginal tape or polyacrylamide hydrogel treatment. The primary outcome was patient satisfaction and secondary outcomes were effectiveness in reducing urinary leakage and complications at 1-year followup. For statistical power significance was considered at 5%, power was set at 80% and the noninferiority limit was 20% with a 10% expected dropout rate.
RESULTS: A total of 224 women with primary stress urinary incontinence entered the study between September 28, 2015 and March 1, 2017. Of the women 111 were randomized to tension-free vaginal tape and 113 were randomized to polyacrylamide hydrogel. At 1 year a satisfaction score of 80 or greater on a visual analogue scale of 0 to 100 was reached in 95.0% and 59.8% of patients treated with tension-free vaginal tape and polyacrylamide hydrogel, respectively. Thus, polyacrylamide hydrogel did not meet the noninferiority criteria set in our study. As secondary outcomes, the cough stress test was negative in 95.0% of tension-free vaginal tape cases vs 66.4% of polyacrylamide hydrogel cases (difference 28.6%, 95% CI 18.4-38.5). However, most perioperative complications, including those in 19 tension-free vaginal tape cases vs 3 polyacrylamide hydrogel cases (difference 16.0%, 95% CI 7.8-24.9), and all 6 reoperations due to complications (difference 5.9%, 95% CI 1.2-12.4) were associated with tension-free vaginal tape.
CONCLUSIONS: Mid urethral tension-free vaginal tape slings were associated with better satisfaction and cure rates than polyacrylamide hydrogel in women with primary stress urinary incontinence. However, complications were mainly associated with tension-free vaginal tape. Thus, tension-free vaginal tape should be offered as first line treatment in women who expect to be completely cured by the initial treatment and are willing to accept the complication risks. Since polyacrylamide hydrogel treatment also provides high satisfaction and cure rates, women with primary stress urinary incontinence can be offered polyacrylamide hydrogel as an alternative treatment.

Entities:  

Keywords:  hydrogels; risk; stress; suburethral slings; urethra; urinary incontinence

Year:  2019        PMID: 31479396     DOI: 10.1097/JU.0000000000000517

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  8 in total

Review 1.  Update on Urethral Bulking for Stress Urinary Incontinence in Women.

Authors:  Yu Zheng; Eric Rovner
Journal:  Curr Urol Rep       Date:  2022-07-04       Impact factor: 2.862

Review 2.  Up-to-Date Procedures in Female Stress Urinary Incontinence Surgery: A Concise Review on Bulking Agents Procedures.

Authors:  Maurizio Serati; Andrea Braga; Stefano Salvatore; Marco Torella; Maria Carmela Di Dedda; Chiara Scancarello; Chiara Cimmino; Andrea De Rosa; Matteo Frigerio; Massimo Candiani; Alessandro Ferdinando Ruffolo
Journal:  Medicina (Kaunas)       Date:  2022-06-08       Impact factor: 2.948

Review 3.  Hydrogels for Tissue Engineering: Addressing Key Design Needs Toward Clinical Translation.

Authors:  Fei Xu; Chloe Dawson; Makenzie Lamb; Eva Mueller; Evan Stefanek; Mohsen Akbari; Todd Hoare
Journal:  Front Bioeng Biotechnol       Date:  2022-05-05

4.  What a mesh! An Australian experience using national female continence surgery trends over 20 years.

Authors:  Aoife McVey; Liang G Qu; Garson Chan; Marlon Perera; Janelle Brennan; Eric Chung; Johan Gani
Journal:  World J Urol       Date:  2021-04-09       Impact factor: 4.226

5.  Risk factors of postpartum stress urinary incontinence in primiparas: What should we care.

Authors:  Jiejun Gao; Xinru Liu; Yan Zuo; Xiaocui Li
Journal:  Medicine (Baltimore)       Date:  2021-05-21       Impact factor: 1.817

6.  Patients' satisfaction and safety of bulk injection therapy Urolastic for treatment of stress urinary incontinence: A cross-sectional study.

Authors:  Fenne M Casteleijn; Claudia R Kowalik; Claudia Berends; Mija Blaganje; Mateja Lasić Pecev; Ellen van der Linden; Sandra E Zwolsman; Jan-Paul W R Roovers; Pieter Minnee
Journal:  Neurourol Urodyn       Date:  2020-06-11       Impact factor: 2.696

7.  Combination therapy with botulinum toxin and bulking agent-An efficient, sustainable, and safe method to treat elderly women with mixed urinary incontinence.

Authors:  Volker Viereck; Marianne Gamper; Claudia Walser; Debra Fesslmeier; Julia Münst; Irena Zivanovic
Journal:  Neurourol Urodyn       Date:  2021-08-03       Impact factor: 2.367

8.  Seven-year efficacy and safety outcomes of Bulkamid for the treatment of stress urinary incontinence.

Authors:  Torsten Brosche; Annette Kuhn; Kurt Lobodasch; Eric R Sokol
Journal:  Neurourol Urodyn       Date:  2021-01-07       Impact factor: 2.367

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.